- Home
- LPCN vs CVR Comparison
LPCN vs CVR Comparison
Compare LPCN & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- CVR
- Stock Information
- Founded
- LPCN 1997
- CVR 1920
- Country
- LPCN United States
- CVR United States
- Employees
- LPCN N/A
- CVR N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- CVR Industrial Machinery/Components
- Sector
- LPCN Health Care
- CVR Industrials
- Exchange
- LPCN Nasdaq
- CVR Nasdaq
- Market Cap
- LPCN 16.1M
- CVR 14.9M
- IPO Year
- LPCN N/A
- CVR N/A
- Fundamental
- Price
- LPCN $3.10
- CVR $9.30
- Analyst Decision
- LPCN Strong Buy
- CVR
- Analyst Count
- LPCN 1
- CVR 0
- Target Price
- LPCN $10.00
- CVR N/A
- AVG Volume (30 Days)
- LPCN 10.3K
- CVR 5.6K
- Earning Date
- LPCN 05-08-2025
- CVR 05-09-2025
- Dividend Yield
- LPCN N/A
- CVR 1.29%
- EPS Growth
- LPCN N/A
- CVR N/A
- EPS
- LPCN N/A
- CVR N/A
- Revenue
- LPCN $11,198,144.00
- CVR $26,986,627.00
- Revenue This Year
- LPCN N/A
- CVR N/A
- Revenue Next Year
- LPCN N/A
- CVR N/A
- P/E Ratio
- LPCN N/A
- CVR N/A
- Revenue Growth
- LPCN N/A
- CVR N/A
- 52 Week Low
- LPCN $2.75
- CVR $8.25
- 52 Week High
- LPCN $11.79
- CVR $22.27
- Technical
- Relative Strength Index (RSI)
- LPCN 46.56
- CVR 36.55
- Support Level
- LPCN $2.82
- CVR $8.25
- Resistance Level
- LPCN $3.27
- CVR $9.49
- Average True Range (ATR)
- LPCN 0.23
- CVR 0.56
- MACD
- LPCN 0.01
- CVR 0.00
- Stochastic Oscillator
- LPCN 58.92
- CVR 41.18
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment. Geographically, the majority is from the United States.